|
1YJD
Crystal structure of human CD28 in complex with the Fab fragment of a mitogenic antibody (5.11A1)
Deposited 2005-01-14
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain C
17–152(136 aa)
Fragment:Extracellular region
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.9;294 K;PEG 3350, magnesium formate, pH 5.9, VAPOR DIFFUSION, SITTING DROP, temperature 294K
|
Resolution 2.70 Å
R-free 0.282
|
|
3WA4
Grb2 SH2 domain/CD28-derived peptide complex
Deposited 2013-04-23
|
Different construct
Different mutation/modification
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
189–196(8 aa)
Fragment:fragment peptide, UNP residues 190-195
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;0.1M HEPES, 1.25M sodium acetate, 0.1M cadmium sulfate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 1.35 Å
R-free 0.209
|
|
3WA4
Grb2 SH2 domain/CD28-derived peptide complex
Deposited 2013-04-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
189–196(8 aa)
Fragment:fragment peptide, UNP residues 190-195
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
CD CADMIUM ION × 1
ACY ACETIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;0.1M HEPES, 1.25M sodium acetate, 0.1M cadmium sulfate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 1.35 Å
R-free 0.209
|
|
5AUL
PI3K p85 C-terminal SH2 domain/CD28-derived peptide complex
Deposited 2015-04-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
189–196(8 aa)
Fragment:UNP residues 189-196
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;100 mM Sodium Acetate trihydrate, 200 mM Ammonium Acetate, 30% PEG4000
|
Resolution 1.10 Å
R-free 0.160
|
|
5GJH
Gads SH2 domain/CD28-derived peptide complex
Deposited 2016-06-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
189–196(8 aa)
Fragment:UNP residues 189-196
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;100 mM HEPES-NaOH, 10% PEG 6000, 20% MPD
|
Resolution 1.20 Å
R-free 0.170
|
|
5GJH
Gads SH2 domain/CD28-derived peptide complex
Deposited 2016-06-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
189–196(8 aa)
Fragment:UNP residues 189-196
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;100 mM HEPES-NaOH, 10% PEG 6000, 20% MPD
|
Resolution 1.20 Å
R-free 0.170
|
|
5GJI
PI3K p85 N-terminal SH2 domain/CD28-derived peptide complex
Deposited 2016-06-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
189–196(8 aa)
Fragment:UNP residues 189-196
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
SO4 SULFATE ION × 3
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;293 K;100mM Sodium acetate trihydrate, 30% PEG MME 2000, 200mM Ammonium sulfate
|
Resolution 0.90 Å
R-free 0.145
|
|
6O8D
Anti-CD28xCD3 CODV Fab bound to CD28
Deposited 2019-03-09
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain C
33–150(118 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277 K;26% PEG3350, 0.75% myo-inositol, 0.263M potassium citrate tribasic monohydrate
|
Resolution 3.55 Å
R-free 0.356
|
|
7PPN
SHP2 catalytic domain in complex with CD28 (183-198) phosphopeptide (pTyr-191, p-Thr-195)
Deposited 2021-09-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
183–198(16 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;277 K;10% PEG 20000, 100 mM Citrate buffer pH 5.5, 50 mM EDTA
|
Resolution 1.90 Å
R-free 0.207
|
|
7VU5
Structure of the transmembrane domain of the CD28 dimer
Deposited 2021-11-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
148–188(41 aa)
Chain B
148–188(41 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6;310 K;Ionic strength (raw mmCIF value) 25;Pressure 1
NMR sample composition
0.6 mM U-13C; U-15N; 75%-2H CD28_TM, 25 mM MES, 30 mM DMPC, 60 mM DHPC, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.6 mM [U-13C; U-15N] CD28_TM, 25 mM MES, 30 mM acyl chain U-2H DMPC, 60 mM acyl chain U-2H DHPC, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.6 mM U-15N; U-2H CD28_TM, 0.6 mM [U-13C] CD28_TM, 25 mM MES, 30 mM acyl chain U-2H DMPC, 60 mM acyl chain U-2H DHPC, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.2 mM U-15N; 15%-13C CD28_TM, 25 mM MES, 30 mM acyl chain U-2H DMPC, 60 mM acyl chain U-2H DHPC, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
8S6Z
CD28 in complex with the antibody Fab fragment AI3
Deposited 2024-02-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
19–152(134 aa)
|
Not recorded
|
IMD IMIDAZOLE × 4
GOL GLYCEROL × 3
ZN ZINC ION × 13
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.4;293 K;Crystallization trials were set up using the CD28-AI3 Fab at 15.8 mg/mL in phosphate buffered saline (PBS) pH 7.4. Drops were set up using 100 nl protein and 100 nL reservoir solution containing 200 mM zinc acetate, 0.1 M imidazole pH 8.0, 20% w/v PEG 3000.
|
Resolution 3.05 Å
R-free 0.258
|
|
8S6Z
CD28 in complex with the antibody Fab fragment AI3
Deposited 2024-02-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain F
19–152(134 aa)
|
Not recorded
|
IMD IMIDAZOLE × 3
GOL GLYCEROL × 3
ZN ZINC ION × 13
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.4;293 K;Crystallization trials were set up using the CD28-AI3 Fab at 15.8 mg/mL in phosphate buffered saline (PBS) pH 7.4. Drops were set up using 100 nl protein and 100 nL reservoir solution containing 200 mM zinc acetate, 0.1 M imidazole pH 8.0, 20% w/v PEG 3000.
|
Resolution 3.05 Å
R-free 0.258
|